SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-027683
Filing Date
2020-05-07
Accepted
2020-05-07 16:26:43
Documents
2
Period of Report
2020-05-05

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4034
2 POA DOCUMENT poa.txt EX-24.4_913291 3566
  Complete submission text file 0001209191-20-027683.txt   9168
Mailing Address SUITE 360 - 1616 EASTLAKE AVE EAST SEATTLE WA 98102
Business Address SUITE 360 - 1616 EASTLAKE AVE EAST SEATTLE WA 98102 206-732-2133
Neoleukin Therapeutics, Inc. (Issuer) CIK: 0001404644 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 331 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address
Noonberg Sarah B. (Reporting) CIK: 0001706301 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36327 | Film No.: 20856878